Raras
Buscar doenças, sintomas, genes...
Deficiência de biotinidase
ORPHA:79241CID-10 · E53.8CID-11 · 5C50.E0OMIM 253260DOENÇA RARA

Forma de início tardio de deficiência múltipla de carboxilase, um erro congênito do metabolismo da biotina que, se não tratado, é caracterizado por convulsões, dificuldades respiratórias, hipotonia, erupção cutânea, alopecia, perda auditiva e atraso no desenvolvimento.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Forma de início tardio de deficiência múltipla de carboxilase, um erro congênito do metabolismo da biotina que, se não tratado, é caracterizado por convulsões, dificuldades respiratórias, hipotonia, erupção cutânea, alopecia, perda auditiva e atraso no desenvolvimento.

Pesquisas ativas
2 ensaios
8 total registrados no ClinicalTrials.gov
Publicações científicas
548 artigos
Último publicado: 2026 Apr 6

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adolescent
+ adult, childhood, infancy, neonatal
🏥
SUS: Cobertura mínimaScore: 10%
Triagem neonatal (Fase 1)CID-10: E53.8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
14 sintomas
👁️
Olhos
5 sintomas
🧬
Pele e cabelo
5 sintomas
🛡️
Imunológico
4 sintomas
🫃
Digestivo
4 sintomas
👂
Ouvidos
2 sintomas

+ 14 sintomas em outras categorias

Características mais comuns

90%prev.
Atividade diminuída da biotinidase
Muito frequente (99-80%)
87%prev.
Hipotonia
Frequente (79-30%)
86%prev.
Acidúria orgânica
Muito frequente (99-80%)
81%prev.
Cetoacidose metabólica
Muito frequente (99-80%)
77%prev.
Alopecia
Ocasional (29-5%)
71%prev.
Atraso global do desenvolvimento
Ocasional (29-5%)
52sintomas
Muito frequente (4)
Frequente (12)
Ocasional (23)
Sem dados (13)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 52 características clínicas mais associadas, ordenadas por frequência.

Atividade diminuída da biotinidaseDecreased biotinidase activity
Muito frequente (99-80%)90%
HipotoniaHypotonia
Frequente (79-30%)87%
Acidúria orgânicaOrganic aciduria
Muito frequente (99-80%)86%
Cetoacidose metabólicaMetabolic ketoacidosis
Muito frequente (99-80%)81%
Alopecia
Ocasional (29-5%)77%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico548PubMed
Últimos 10 anos200publicações
Pico202028 papers
Linha do tempo
2026Hoje · 2026🧪 2006Primeiro ensaio clínico📈 2020Ano de pico
Publicações por ano (últimos 10 anos)

Triagem neonatal (Teste do Pezinho)

👶
Teste: Atividade de biotinidase em sangue seco
Fase 1 do PNTNTriagem nacionalimplemented_nationally
Incidência no Brasil: 1:60.000

A triagem neonatal permite diagnóstico precoce e início imediato do tratamento.

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.

BTDBiotinidaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalytic release of biotin from biocytin, the product of biotin-dependent carboxylases degradation

LOCALIZAÇÃO

Secreted, extracellular space

VIAS BIOLÓGICAS (1)
Biotin transport and metabolism
MECANISMO DE DOENÇA

Biotinidase deficiency

A juvenile form of multiple carboxylase deficiency, an autosomal recessive disorder of biotin metabolism, characterized by ketoacidosis, hyperammonemia, excretion of abnormal organic acid metabolites, and dermatitis. Biotinidase deficiency is characterized by seizures, hypotonia, skin rash, alopecia, ataxia, hearing loss, and optic atrophy. If untreated, symptoms usually become progressively worse, and coma and death may occur.

OUTRAS DOENÇAS (1)
biotinidase deficiency
HGNC:1122UniProt:P43251

Variantes genéticas (ClinVar)

379 variantes patogênicas registradas no ClinVar.

🧬 BTD: NM_001370658.1(BTD):c.1430C>T (p.Pro477Leu) ()
🧬 BTD: NM_001370658.1(BTD):c.641C>A (p.Thr214Asn) ()
🧬 BTD: NM_001370658.1(BTD):c.184G>A (p.Ala62Thr) ()
🧬 BTD: NM_001370658.1(BTD):c.1493_1494dup (p.Tyr499fs) ()
🧬 BTD: NM_001370658.1(BTD):c.158C>T (p.Pro53Leu) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 680 variantes classificadas pelo ClinVar.

204
272
204
Patogênica (30.0%)
VUS (40.0%)
Benigna (30.0%)
VARIANTES MAIS SIGNIFICATIVAS
BTD: NM_001370658.1(BTD):c.1430C>T (p.Pro477Leu) [Likely pathogenic]
BTD: NM_001370658.1(BTD):c.641C>A (p.Thr214Asn) [Likely pathogenic]
BTD: NM_001370658.1(BTD):c.184G>A (p.Ala62Thr) [Likely pathogenic]
BTD: NM_001370658.1(BTD):c.1493_1494dup (p.Tyr499fs) [Pathogenic]
BTD: NM_001370658.1(BTD):c.158C>T (p.Pro53Leu) [Pathogenic]

Vias biológicas (Reactome)

2 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 21
·Pré-clínico4
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 5 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Deficiência de biotinidase

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

8 ensaios clínicos encontrados, 2 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
231 papers (10 anos)
#1

The impact of hematocrit, punch location, and cellular interference on neonatal screening for biotinidase deficiency.

The Turkish journal of pediatrics2026 Feb 27

Biotinidase deficiency is a core condition in newborn screening programs worldwide. While fluorometric enzyme activity assays from dried blood spots (DBS) are the standard first-tier test, their accuracy can be susceptible to pre-analytical variation. To date, the specific impact of hematocrit (HCT), punch location, and cellular interference on fluorometric biotinidase measurements have not been systematically examined. We prepared blood pools to isolate specific variables: a reference pool at 50% HCT (HCT50), a low-HCT pool at 34% (HCT34), and a leukocyte-depleted pool (HCT50(-W)). Secondary pools were created with biotinidase activities of 0, 50, 100, and 200 U. DBS samples were prepared from all pools. Biotinidase activity was measured fluorometrically from central and peripheral punches (n=12 per condition). Statistical analysis included t-tests and Cohen's d effect sizes, with a >10% deviation set as the threshold for clinical significance. Our results demonstrated a significant systematic bias: Peripheral punches yielded higher biotinidase activity than central punches across all sample types (13.36%-16.61% difference, p20% higher values at the critical biotinidase activity-50 U level. Crucially, leukocyte depletion resulted in a statistically significant decrease in measured activity (~10.6%, p.

#2

Profound Biotinidase Deficiency as a Treatable Cause of Pediatric Diffuse Leukoencephalopathy and Diffusion Restriction.

Journal of child neurology2026 Mar 18

BackgroundBiotinidase deficiency (BTD) is a rare, autosomal-recessive neurometabolic disorder due to biallelic pathogenic variants in the BTD gene. Diffuse leukoencephalopathy with diffusion restriction on neuroimaging is a rare but reversible radiologic pattern associated with BTD.ObjectivesTo describe the clinico-radiologic profile of 3 children with genetically confirmed profound BTD presenting with diffuse leukoencephalopathy and diffusion restriction, and to compare findings with similar cases reported in the literature.MethodsConsecutive children attending the pediatric neurology clinic were evaluated for early-onset seizures, developmental delay, respiratory symptoms, and encephalopathy. Clinical, biochemical, genetic, neurophysiological, and magnetic resonance imaging findings were analysed. Whole exome sequencing confirmed BTD gene variants. A systematic PubMed search and literature review were conducted using specified MeSH terms to identify similar cases.ResultsThree male children from 2 families were evaluated. All cases had early-onset seizures, developmental delay, and profound biotinidase deficiency. Stridor was noted in 2 cases. Genetic analysis identified 2 pathogenic BTD variants: homozygous, frameshift deletion (c.38_44delinsTCC; p.Cys13PhefsTer36), and another homozygous, nonsense variant (c.946C>T; p.Gln316Ter). Neuroimaging revealed diffuse leukoencephalopathy with intense diffusion restriction in all, which reversed completely with biotin supplementation. Seizures and encephalopathy resolved while optic neuropathy progressed despite treatment. Literature review identified 13 additional cases with diffusion restriction, and all of them had an early presentation.ConclusionsProfound BTD may present with diffuse leukoencephalopathy and diffusion restriction, mimicking neuroinflammatory or degenerative conditions. This reversible metabolic disorder should be considered in the differential diagnosis of pediatric white matter disorders. Early diagnosis and biotin supplementation are crucial for neurologic recovery although optic and auditory neuropathy may progress despite treatment.

#3

Assessment of biotinidase activity changes over time in biotinidase deficient patients.

Frontiers in pediatrics2026

Biotinidase enzyme is responsible for recycling biotin which is essential for metabolic functions. Loss of function mutations in the BTD gene causes biotinidase deficiency (BTD). It is diagnosed by measuring biotinidase activity and it can lead to severe neurological symptoms. We aimed to evaluate biotinidase activity changes in patients with BTD over time. 194 patients with BTD were enrolled. Clinical, laboratory and genetic data of the patients were retrospectively evaluated. Patients with enzyme activity below 10% of normal were diagnosed with profound BTD while patients with enzyme activity between 10% and 30% were diagnosed with partial BTD. 104 (53.6%) patients were male, most patients were diagnosed at screening (n = 183, 94.3%) and the mean age at the time of diagnosis for symptomatic patients was 82.7 ± 22.8 (range: 1-216) months. Two (1%) patients had profound BTD, 168 (86.6%) patients had partial BTD, and 24 (12.4%) patients had more than 30% of normal biotinidase activity. Overall, the last measured biotinidase activity levels were significantly higher than the initial measurements (p < 0.0001). This finding was valid for all subgroups classified according to birth week, birth weight, and consanguineous marriage status. The increase in enzyme rate over time was slower in children of consanguineous marriages compared to children who were not. This study showed that biotinidase activity increased in BTD patients over time and repeated measurements of biotinidase would be a better approach to evaluate BTD. In addition, consanguineous marriage may be a risk factor for a worse prognosis in BTD.

#4

Newborn screening in an Eastern Indian province: prevalence and trends from a burgeoning newborn screening unit.

Journal of tropical pediatrics2026 Jan 02

Neonatal screening has not been demanded by pediatricians nor parents in India because of limited resources, inadequate health information, early hospital discharges, a large rate of deliveries at home, and challenges with follow-up of results. This study was conducted based on the laboratory e-records from the Newborn Screening Unit, where Dried Blood Spot-based analysis was performed for G6PD deficiency, congenital adrenal hyperplasia, neonatal hypothyroidism, biotinidase deficiency, and galactosemia. The total study population comprised 3210 neonates. Overall, 329 children (10.2%) had some form of inherited disorder, and 12 (0.4%) suffered from two disorders concomitantly. The highest number of children were suffering from partial biotinidase deficiency (4.5%), followed by G6PD deficiency (2.7%). There was no significant difference in the levels of measured analytes in males and females, except for 17-OHP, which was significantly higher in males. Compared with females, males were more likely to have G6PD and biotinidase deficiency. Our study provides a snapshot of five inherited disorders previously unexamined by neonatal screening in Eastern India. We found a high prevalence of G6PD deficiency and other substantive neonatal conditions. Now that the significant prevalence of these disorders is known, stakeholders should work with policy-makers to institute national-level screening to determine their distribution in the broader population and address them in affected groups. Further studies are needed to identify effective implementation strategies, overcome financial and logistical barriers to an NBS program, and assess whether such a program can reach and benefit all communities, especially the most vulnerable.

#5

Untargeted Metabolomic and Lipidomic Profiling Reveals Distinct Biochemical Patterns in Treated Biotinidase Deficiency.

International journal of molecular sciences2026 Jan 20

Biotinidase deficiency is an autosomal recessive disorder that disrupts biotin recycling and multiple carboxylase-dependent pathways. Early and continuous biotin therapy prevents major clinical manifestations, but its long-term biochemical effects remain unclear. This study applied untargeted metabolomic and lipidomic profiling in 54 pediatric patients with genetically confirmed BD receiving regular biotin supplementation and 30 age- and sex-matched controls. Multivariate analyses and pathway enrichment revealed distinct biochemical signatures involving amino acid, energy, and lipid metabolism. Reduced levels of serine, glycine, threonine, and tricarboxylic acid cycle intermediates suggested modified mitochondrial flux, while octopine, exhibiting an approximately 11-fold increase, was the metabolite best able to discriminate between the groups. Lipidomic profiling indicated elevations in sphingolipids, phosphatidylcholines, long-chain fatty acids, and acylcarnitines, consistent with systemic lipid remodeling. These coordinated alterations imply metabolic adaptations to sustained biotin exposure rather than ongoing pathology. Octopine and selected lipid species may represent biochemical indicators of this adaptive state. Overall, the findings highlight that clinically stable children with Biotinidase deficiency exhibit unique metabolic and lipidomic patterns reflecting long-term compensatory mechanisms, underscoring the value of combined omics approaches for understanding disease-specific homeostasis and informing personalized follow-up strategies.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC358 artigos no totalmostrando 195

2026

The impact of hematocrit, punch location, and cellular interference on neonatal screening for biotinidase deficiency.

The Turkish journal of pediatrics
2026

Profound Biotinidase Deficiency as a Treatable Cause of Pediatric Diffuse Leukoencephalopathy and Diffusion Restriction.

Journal of child neurology
2026

Assessment of biotinidase activity changes over time in biotinidase deficient patients.

Frontiers in pediatrics
2026

Biotin Deficiency Alters the Expression Profile of Colonic microRNAs: Possible Contribution to the Alterations in Expression of Proteins Involved in the Maintenance of Colonic Physiology and Inflammation.

Nutrients
2026

Newborn screening in an Eastern Indian province: prevalence and trends from a burgeoning newborn screening unit.

Journal of tropical pediatrics
2026

Untargeted Metabolomic and Lipidomic Profiling Reveals Distinct Biochemical Patterns in Treated Biotinidase Deficiency.

International journal of molecular sciences
2026

Screening for Biotinidase deficiency in children with spinal cord demyelination.

Multiple sclerosis and related disorders
2025

Expanded Newborn Screening for Inborn Errors of Metabolism at a Single Center in Louisiana (2005-2024): Outcomes.

International journal of neonatal screening
2025

A Review of "My Life in Science: The Story of Biotinidase Deficiency" by Dr. Barry Wolf.

International journal of neonatal screening
2025

Biotinidase deficiency deterioration in the second decade, presenting as treatable cerebellar ataxia and encephalopathy masquerading as demyelination.

BMJ case reports
2025

Clinical and molecular characterization of 14 Egyptian children with fructose-1,6-bisphosphatase deficiency.

Italian journal of pediatrics
2025

Evaluation of readability and understandability of biotinidase deficiency information online.

Journal of community genetics
2025

Biotinidase deficiency presenting with status epilepticus and cerebellar infarction in an infant: a case report.

Annals of medicine and surgery (2012)
2026

Exploring Secondary Biotinidase Deficiency and Biotin Supplementation in PMM2-CDG.

Neuropediatrics
2025

Genomic and Structural Investigation of Mutations in Biotinidase (BTD) Gene Deficiency in Greater Middle Eastern Cohort: Insights from Molecular Dynamics Study.

Biomedicines
2025

Enzymatic Evolution and Longitudinal Recovery in Biotinidase Deficiency: Genotypic and Clinical Insights from the Follow-Up of a Newborn-Screened Cohort in Emilia-Romagna, Italy.

Metabolites
2025

Dual molecular genetic diagnosis with combined malonic and methylmalonic aciduria (CMAMMA): implications of coexisting genetic disorders on clinical presentation.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2025

Neuroimaging Findings in Congenital Biotinidase Deficiency: A Case Report.

Cureus
2026

Pathogenic Variants in Mennonites From Southern Brazil: Implications for Preventive Measures in Public Health.

Clinical genetics
2025

Qatar's National Expanded Metabolic Newborn Screening Program: Incidence and Outcomes.

International journal of neonatal screening
2025

Beyond the homozygous paradigm: symptomatic partial biotinidase deficiency in a heterozygous child-first case report from Nepal.

BMC pediatrics
2025

Newborn screening programs promote vaccine acceptance among parents in Turkey: a cross-sectional study.

Postgraduate medicine
2025

Biotinidase Deficiency Induced Optic Neuropathy: A Case Report and Literature Review.

Neuro-ophthalmology (Aeolus Press)
2025

Biotinidase Deficiency: Report of a Tunisian Case With Neuromyelitis Optica-Like Presentation and Review of the Literature.

Case reports in neurological medicine
2025

Developmental outcomes of children with biotinidase deficiency and the psychological state of their parents.

European journal of pediatrics
2025

Optimizing Biotinidase Activity Assays: Insights From Clinical and Laboratory Evaluation From a Low-Middle Income Country.

Cureus
2025

Hepatoerythropoietic Porphyria with Coexisting BTD And CNGB1 Genetic Mutations: A First Case Report.

European journal of case reports in internal medicine
2024

Implementing and validating newborn screening for inborn errors of metabolism in South India: a 2-year observational study at a tertiary care hospital.

BMJ public health
2025

Evaluating reproductive carrier screening using biotinidase deficiency as a model: Variants identified, variant rates, and management.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

Feasibility of clinical newborn metabolic screening in a high-volume maternity center in Nepal.

BMC global and public health
2024

Biotinidase deficiency-masquerade of primary immunodeficiency disease in neonate.

BMJ case reports
2024

Case report: A case of holocarboxylase synthetase deficiency with respiratory tract as the initial symptom.

Frontiers in genetics
2024

Comprehensive analysis of genotypic and phenotypic characteristics of biotinidase deficiency patients in the eastern region of Türkiye.

The Turkish journal of pediatrics
2025

Optimising 3D printed medications for rare diseases: In-line mass uniformity testing in direct powder extrusion 3D printing.

International journal of pharmaceutics
2025

Identification of the mutations in BTD gene in Iranian patients with biotinidase deficiency and evaluating their genotype-phenotype correlations.

Gene
2024

A retrospective study on biotinidase deficiency: analysis of the Eastern Anatolia region patient cohort.

Scandinavian journal of clinical and laboratory investigation
2025

Urine organic acid metabolomic profiling by gas chromatography mass spectrometry: Assessment of solvent extract evaporation parameters on the recovery of key diagnostic metabolites.

Clinica chimica acta; international journal of clinical chemistry
2024

Outcome of Expanded Newborn Screening Among 194 000 Neonates at Northeast México.

Global pediatric health
2024

Alterations in optical coherence tomography and optical coherence tomography angiography findings in children with partial biotinidase deficiency.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2024

[Epilepsy and inborn errors of metabolism].

Revista de neurologia
2024

Molecular Mechanisms of Biotin in Modulating Inflammatory Diseases.

Nutrients
2024

Biallelic loss-of-function variations in BTD cause profound biotinidase deficiency in an Indian patient.

Molecular biology reports
2024

Oxford nanopore sequencing-based assay for BTD gene screening: Design, clinical validation, and variant frequency assessment in the Turkish population.

Gene
2024

Case report of biotinidase deficiency in a 16-month-old child with emphasis on skin manifestations.

Postepy dermatologii i alergologii
2024

Atypical presentation of biotinidase deficiency: masquerading neuromyelitis optica spectrum disorder.

BMJ case reports
2024

Juvenile Parkinsonism and Cognitive Impairment in a Patient with Compound Heterozygous Variants in the BTD Gene- an Unusual Presentation of Biotinidase Deficiency.

Movement disorders clinical practice
2024

Biotin Homeostasis and Human Disorders: Recent Findings and Perspectives.

International journal of molecular sciences
2024

Laryngeal stridor in children caused by reversible metabolic disease.

BMJ case reports
2024

A new case of sodium-dependent multivitamin transporter defect occurring as a life-threatening condition responsive to early vitamin supplementation and literature review.

Molecular genetics &amp; genomic medicine
2024

Optic Neuropathy and Myelopathy in a Teenager With Biotinidase Deficiency.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2024

Biotinidase biochemical and molecular analyses: Experience at a large reference laboratory.

Pediatrics international : official journal of the Japan Pediatric Society
2024

Ophthalmic manifestations of biotinidase deficiency: report of a case and review of literature.

Ophthalmic genetics
2024

Accurate determination of Biotinidase activity in serum by HPLC and its utilization as second tier test for the confirmation of initial positive newborn screening results.

Molecular genetics and metabolism reports
2024

Evaluation of clinical, laboratory, and molecular genetic features of patients with biotinidase deficiency.

European journal of pediatrics
2023

Early-infantile developmental and epileptic encephalopathy: the aetiologies, phenotypic differences and outcomes-a prospective observational study.

Brain communications
2023

Novel SLC5A6 mutations lead to B lymphocyte maturation defects with metabolic abnormality rescuable by biotin replenishment.

Clinical immunology (Orlando, Fla.)
2023

Longitudinally Extensive Transverse Myelitis with Optic Neuritis Related to Profound Biotinidase Deficiency: NMOSD Mimic!

Annals of Indian Academy of Neurology
2023

Analysis of Biotinidase Activity in Serum by Digital Imaging Colorimetry Detection.

ACS omega
2023

Determination of Carrier Frequency of Actionable Pathogenic Variants in Autosomal Recessive Genetic Diseases in the Turkish Cypriot Population.

Genes
2023

Effect of Biotin Starvation on Gene Expression in Komagataella phaffii Cells.

Biochemistry. Biokhimiia
2024

Sequence variants in the BTD underlying biotinidase deficiency in families of Pakistani origin.

The journal of gene medicine
2023

A different approach to the evaluation of the genotype-phenotype relationship in biotinidase deficiency: repeated measurement of biotinidase enzyme activity.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2022

A retrospective study on newborn screening for metabolic disorders.

Bioinformation
2023

Evaluation of newborn screening in the state of Mato Grosso from 2005 to 2019.

Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo
2023

Biotinidase Deficiency in the Second Decade with Atypical Neuroimaging Findings.

Advanced biomedical research
2023

Unusual stroke cause: bilaterally fornix infarction in a patient with biotinidase deficiency.

QJM : monthly journal of the Association of Physicians
2023

Delayed Biotin Therapy in a Child with Atypical Profound Biotinidase Deficiency: Late Arrival of the Truth and a Lesson Worth Thinking.

International journal of molecular sciences
2023

Tetraparesis as an initial manifestation of biotinidase deficiency: a case report.

Annals of medicine and surgery (2012)
2023

Identification and characterization of the largest deletion in the PCCA gene causing severe acute early-onset form of propionic acidemia.

Molecular genetics and genomics : MGG
2023

Evaluation of 700 patients referred with a preliminary diagnosis of biotinidase deficiency by the national newborn metabolic screening program: a single-center experience.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2023

The Enigma of Periorificial Desquamating Lesions in a Child.

Indian dermatology online journal
2023

Twin Premature Infants With Riboflavin and Biotin Deficiency Presenting With Refractory Lactic Acidosis, Rash, and Multiorgan Failure During Prolonged Parenteral Nutrition.

Journal of investigative medicine high impact case reports
2023

Newborn Screening Conditions: Early Intervention and Probability of Developmental Delay.

Journal of developmental and behavioral pediatrics : JDBP
2023

[Holocarboxylase synthetase deficiency induced by HLCS gene mutations: a rare disease study].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2023

Biotinidase deficiency: What have we learned in forty years?

Molecular genetics and metabolism
2023

Neuroimaging Features of Biotinidase Deficiency.

AJNR. American journal of neuroradiology
2023

A Rare Biotinidase Deficiency in the Pediatrics Population: Genotype-Phenotype Analysis.

Journal of pediatric genetics
2023

Biotin Deficiency Induces Intestinal Dysbiosis Associated with an Inflammatory Bowel Disease-like Phenotype.

Nutrients
2023

Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics.

Genetics in medicine : official journal of the American College of Medical Genetics
2022

Evaluation of patients diagnosed with phenylketonuria and biotinidase deficiency by the newborn screening program: a ten-year retrospective study.

The Turkish journal of pediatrics
2022

A Boy with Sandestig-Stefanova Syndrome and Genital Abnormalities.

Molecular syndromology
2022

Cochlear Implantation in Biotinidase Enzyme Deficiency.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
2022

Effects of biotin deficiency on short term memory: The role of glutamate, glutamic acid, dopamine and protein kinase A.

Brain research
2022

Revisiting the administration of biotin to children with biotin-responsive disorders.

Molecular genetics and metabolism
2022

High Incidence of Partial Biotinidase Deficiency in the First 3 Years of a Regional Newborn Screening Program in Italy.

International journal of environmental research and public health
2022

Detection of IEMs by Mass Spectrometry Techniques in High-Risk Children: A Pilot Study.

Indian journal of pediatrics
2022

Molecular Background and Disease Prevalence of Biotinidase Deficiency in a Polish Population-Data Based on the National Newborn Screening Programme.

Genes
2022

How paediatricians investigate early developmental impairment in the UK: a qualitative descriptive study.

BMC pediatrics
2022

Expert consensus on screening, diagnosis and treatment of multiple carboxylase deficiency.

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
2023

Biotinidase activity is affected by both seasonal temperature and filter collection cards.

Clinical biochemistry
2022

Inherited metabolic diseases mimicking hereditary spastic paraplegia (HSP): a chance for treatment.

Neurogenetics
2022

Pros and Cons of Telemedicine for Inherited Metabolic Disorders in a Developing Country During the COVID-19 Pandemic.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association
2022

Perspective on newborn screening (NBS): Evidence sharing on conditions to be included in NBS in Pakistan.

JPMA. The Journal of the Pakistan Medical Association
2022

Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol.

Annals of hematology
2021

Whole-Exome Sequencing Reveals a Missense Variant c.1612C>T (p.Arg538Cys) in the BTD Gene Leading to Neuromyelitis Optica Spectrum Disorder in Saudi Families.

Frontiers in pediatrics
2022

Recovery of enzyme activity in biotinidase deficient individuals during early childhood.

Journal of inherited metabolic disease
2022

Establishing biotinidase reference interval: A foundation stone for newborn screening of biotinidase deficiency in Pakistan.

JPMA. The Journal of the Pakistan Medical Association
2022

Late Onset Subacute Profound Biotinidase Deficiency Caused by a Novel Homozygous Variant c.466-3T>G in the BTD Gene.

Indian journal of pediatrics
2021

Autism spectrum disorder in patients with inherited metabolic disorders-a large sample from a tertiary center.

The Turkish journal of pediatrics
2022

Serum biotin interference: A troublemaker in hormone immunoassays.

Clinical biochemistry
2021

Brain MRI findings in an infant with congenital biotinidase deficiency.

BMJ case reports
2022

100 years of inherited metabolic disorders in Austria-A national registry of minimal birth prevalence, diagnosis, and clinical outcome of inborn errors of metabolism in Austria between 1921 and 2021.

Journal of inherited metabolic disease
2021

Adult-Onset Biotinidase Deficiency Induces Acutely Progressing Leukoencephalopathy.

Neurology. Clinical practice
2021

Clinical, biochemical and genotypical characteristics in biotinidase deficiency.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2022

Biotinidase deficiency: a boy with angular cheilitis and blepharitis.

International journal of dermatology
2021

BTD Gene Mutations in Biotinidase Deficiency: Genotype-Phenotype Correlation.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
2022

Childhood-onset hereditary spastic paraplegia and its treatable mimics.

Molecular genetics and metabolism
2021

Juvenile progressive optic atrophy as the presenting feature of biotinidase deficiency, a treatable metabolic disorder.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2021

Newborn Screening for Biotinidase Deficiency. The Experience of a Regional Center in Italy.

Frontiers in pediatrics
2021

Clinico-Pathological and Molecular Spectrum of Biotinidase Deficiency- Experience from a Lower Middle-Income Country.

Clinical laboratory
2020

Visual Loss in Biotinidase Deficiency.

Annals of Indian Academy of Neurology
2021

Autism: Screening of inborn errors of metabolism and unexpected results.

Autism research : official journal of the International Society for Autism Research
2021

Partial Biotinidase Deficiency Revealed Imbalances in Acylcarnitines Profile at Tandem Mass Spectrometry Newborn Screening.

International journal of environmental research and public health
2021

Multiple Carboxylase Deficiency Organic Acidemia as a Cause of Infantile Seizures.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
2021

Biotinidase Deficiency Presenting as Recurrent Laryngeal Stridor.

Indian journal of pediatrics
2021

Two novel BTD mutations causing profound biotinidase deficiency in a Chinese patient.

Molecular genetics &amp; genomic medicine
2020

Delayed Diagnosis of Congenital Hypothyroidism in a Child with Trisomy 21 and Biotinidase Deficiency and Successful Use of Levothyroxine Sodium Oral Solution.

Case reports in endocrinology
2021

Biotinidase deficiency is a rare, potentially treatable cause of peripheral neuropathy with or without optic neuropathy in adults.

Molecular genetics and metabolism reports
2022

Rare Treatable Cause of Demyelinating Leukoencephalopathy That One Cannot Afford to Miss.

Journal of pediatric genetics
2020

High frequency of biotinidase deficiency in Italian population identified by newborn screening.

Molecular genetics and metabolism reports
2021

Immunophenotypic analysis of lymphocyte subsets in newborns with biotinidase deficiency.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2020

Severe Distal Motor Involvement in a Non-compliant Adult With Biotinidase Deficiency: The Necessity of Life-Long Biotin Therapy.

Frontiers in neurology
2021

Evaluation of the efficiency of serum biotinidase activity as a newborn screening test in Turkey.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2020

Biotinidase deficiency: A treatable cause of hereditary spastic paraparesis.

Neurology. Genetics
2022

A Treatable Cause of Myelopathy: Biotinidase Deficiency Presenting as Acute Flaccid Paralysis.

Journal of pediatric genetics
2020

Biotinidase Deficiency as a Mimic of Neuromyelitis Optica Spectrum Disorder in Childhood.

JAMA neurology
2020

Diagnosis and management of symptomatic profound biotinidase deficiency in a tertiary care center in Lebanon.

Clinical biochemistry
2020

Biotinidase deficiency characterized by skin and hair findings.

Clinics in dermatology
2020

Automated generation of decision-tree models for the economic assessment of interventions for rare diseases using the RaDiOS ontology.

Journal of biomedical informatics
2020

Biotinidase deficiency presenting as Neuromyelitis Optica Spectrum Disorder.

Brain &amp; development
2021

Developmental and behavioral outcomes of preschool-aged children with biotinidase deficiency identified by newborn screening.

European journal of pediatrics
2020

Vitamin-Responsive Movement Disorders in Children.

Annals of Indian Academy of Neurology
2020

Incidence of newborn screening disorders among 56632 infants in Central Saudi Arabia. A 6-year study.

Saudi medical journal
2020

Biotinidase deficiency in differential diagnosis of neuromyelitis optica spectrum disorder.

Multiple sclerosis and related disorders
2020

Biotinidase Deficiency With Suspected Sotos Syndrome: A Rare Entity.

Cureus
2020

Any individual with multiple sclerosis who markedly improves neurologically with high-doses of biotin should be evaluated for biotinidase deficiency.

Multiple sclerosis journal - experimental, translational and clinical
2020

Biotinidase Deficiency: Prevalence, Impact And Management Strategies.

Pediatric health, medicine and therapeutics
2022

A survey-based study of physician practices regarding biotin supplementation.

The Journal of dermatological treatment
2020

Clinical, biochemical and mutational findings in biotinidase deficiency among Malaysian population.

Molecular genetics and metabolism reports
2020

The novel homozygous p.Asn197_Ser201del mutation in BTD gene is associated with profound biotinidase deficiency in an Iranian consanguineous family.

Molecular biology reports
2021

Reversal of Vision Loss in a 49-Year-Old Man With Progressive Optic Atrophy Due to Profound Biotinidase Deficiency.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2020

Spinal cord demyelination in children: A diagnostic challenge in neuropaediatrics for a good outcome.

Brain &amp; development
2020

Metabolomic Analysis of Liver from Dietary Biotin Deficient Mice.

Journal of nutritional science and vitaminology
2020

[A case of brain liquefaction caused by biotinidase deficiency].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2020

Expanded carrier screening for preconception reproductive risk assessment: Prevalence of carrier status in a Mexican population.

Prenatal diagnosis
2020

Identification and Characterization of BTD Gene Mutations in Jordanian Children with Biotinidase Deficiency.

Journal of personalized medicine
2020

Dietary biotin deficiency decreased growth performance and impaired the immune function of the head kidney, spleen and skin in on-growing grass carp (Ctenopharyngodon idella).

Fish &amp; shellfish immunology
2020

Frequency of biotinidase gene variants and incidence of biotinidase deficiency in the Newborn Screening Program in Minas Gerais, Brazil.

Journal of medical screening
2019

[Clinical and genetic characteristics of 62 children with mitochondrial epilepsy].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2019

Serum Level of Biotin Rather than the Daily Dosage Is the Main Determinant of Interference on Thyroid Function Assays.

Hormone research in paediatrics
2019

Biotin: overview of the treatment of diseases of cutaneous appendages and of hyperseborrhea.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia
2020

Health-care providers' perspectives on uncertainty generated by variant forms of newborn screening targets.

Genetics in medicine : official journal of the American College of Medical Genetics
2020

Biotinidase deficiency in a newborn.

Journal of neonatal-perinatal medicine
2019

Genetic defect of the sodium-dependent multivitamin transporter: A treatable disease, mimicking biotinidase deficiency.

JIMD reports
2019

Effect of BTD gene variants on in vitro biotinidase activity.

Molecular genetics and metabolism
2019

Biotin deficiency in hyperemesis gravidarum.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
2020

Acrodermatitis enteropathica-like skin eruption with neonatal seizures in a child with biotinidase deficiency.

Clinical and experimental dermatology
2019

High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders.

Molecular genetics and metabolism
2019

Epidemiology of rare diseases detected by newborn screening in the Czech Republic.

Central European journal of public health
2019

Effect of perinatal biotin deficiency on auditory pathway of the Wistar-Albino rats.

Acta oto-laryngologica
2019

Biotinidase deficiency: A treatable cause of opticospinal syndrome in young adults✰.

Multiple sclerosis and related disorders
2019

Congenital biotinidase deficiency - MRI findings in two cases.

The Indian journal of radiology &amp; imaging
2019

Novel mutations causing biotinidase deficiency in individuals identified by the newborn screening program in Minas Gerais, Brazil.

American journal of medical genetics. Part A
2019

Biotinidase Deficiency: A Treatable Neurological Inborn Error of Metabolism.

The Israel Medical Association journal : IMAJ
2019

Biotin interference in immunoassays based on biotin-strept(avidin) chemistry: An emerging threat.

Biotechnology advances
2019

Biotin in metabolism, gene expression, and human disease.

Journal of inherited metabolic disease
2019

Genotypic and phenotypic correlations of biotinidase deficiency in the Chinese population.

Orphanet journal of rare diseases
2019

Biotinidase deficiency should be considered in individuals thought to have multiple sclerosis and related disorders.

Multiple sclerosis and related disorders
2019

Owl's Eye Sign in a Reversible Etiology of Spastic Quadriparesis.

Neuropediatrics
2019

Diaper Rash in an Infant with Seizures.

The Journal of pediatrics
2018

Could nodding syndrome in Northern Uganda be a form of autism spectrum disorder? an observational study design.

The Pan African medical journal
2018

Epilepsy in Biotinidase Deficiency Is Distinct from Early Myoclonic Encephalopathy.

Neuropediatrics
2018

Single center experience of biotinidase deficiency: 259 patients and six novel mutations.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2018

Neurological Sequelae due to Inborn Metabolic Diseases in Pediatric Refugees: Challenges in Treating the Untreated.

Neuropediatrics
2018

Actual Insights into Treatable Inborn Errors of Metabolism Causing Epilepsy.

Journal of pediatric neurosciences
2018

Are we missing patients with biotinidase deficiency in France?

Revue neurologique
2018

Reconciling newborn screening and a novel splice variant in BTD associated with partial biotinidase deficiency: a BabySeq Project case report.

Cold Spring Harbor molecular case studies
2018

Multiplex tandem mass spectrometry assay for newborn screening of X-linked adrenoleukodystrophy, biotinidase deficiency, and galactosemia with flexibility to assay other enzyme assays and biomarkers.

Molecular genetics and metabolism
2018

Secondary Hemophagocytic Syndrome Associated with COG6 Gene Defect: Report and Review.

JIMD reports
2017

"Think metabolic" in adults with diagnostic challenges: Biotinidase deficiency as a paradigm disorder.

Neurology. Clinical practice
2018

Clinical features, BTD gene mutations, and their functional studies of eight symptomatic patients with biotinidase deficiency from Southern China.

American journal of medical genetics. Part A
2018

Twenty-seven mutations with three novel pathologenic variants causing biotinidase deficiency: a report of 203 patients from the southeastern part of Turkey.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2018

Coexistence of 2 rare autosomal recessively inherited disorders manifesting with immune deficiency; IL-12 receptor β1 and biotinidase deficiencies.

The Turkish journal of pediatrics
2017

Cost-Effectiveness Methods and Newborn Screening Assessment.

Advances in experimental medicine and biology
2017

[Screening for newborn organic aciduria in Zhejiang province:prevalence, outcome and follow-up].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
2018

Adult-onset biotinidase deficiency: two individuals with severe, but reversible optic neuropathy.

Journal of neurology, neurosurgery, and psychiatry
2018

Characterizing the Biotinidase Deficiency in a Child When Considering a Possible Disease Association.

Journal of pediatric hematology/oncology
2017

Neonatal screening for biotinidase deficiency: A 30-year single center experience.

Molecular genetics and metabolism reports
2017

Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics.

Genetics in medicine : official journal of the American College of Medical Genetics
2016

Diagnostic Dilemma Of Biotinidase Deficiency: Case Of A Child From Pakistan.

Journal of Ayub Medical College, Abbottabad : JAMC
2017

Developmental window of sensorineural deafness in biotinidase-deficient mice.

Journal of inherited metabolic disease
2017

Biotinidase deficiency: Genotype-biochemical phenotype association in Brazilian patients.

PloS one
2016

Comparison of Spectrophotometric and Fluorimetric Methods in Evaluation of Biotinidase Deficiency.

Journal of medical biochemistry
2018

Biotinidase deficiency masquerading as multiple sclerosis?

Multiple sclerosis (Houndmills, Basingstoke, England)
2017

A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: late-onset biotinidase deficiency.

Metabolic brain disease
Ver todos os 358 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Deficiência de biotinidase.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Deficiência de biotinidase

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. The impact of hematocrit, punch location, and cellular interference on neonatal screening for biotinidase deficiency.
    The Turkish journal of pediatrics· 2026· PMID 41871562mais citado
  2. Profound Biotinidase Deficiency as a Treatable Cause of Pediatric Diffuse Leukoencephalopathy and Diffusion Restriction.
    Journal of child neurology· 2026· PMID 41848407mais citado
  3. Assessment of biotinidase activity changes over time in biotinidase deficient patients.
    Frontiers in pediatrics· 2026· PMID 41847504mais citado
  4. Newborn screening in an Eastern Indian province: prevalence and trends from a burgeoning newborn screening unit.
    Journal of tropical pediatrics· 2026· PMID 41620979mais citado
  5. Untargeted Metabolomic and Lipidomic Profiling Reveals Distinct Biochemical Patterns in Treated Biotinidase Deficiency.
    International journal of molecular sciences· 2026· PMID 41596672mais citado
  6. Auditory function at birth in infants with biotinidase deficiency.
    Int J Pediatr Otorhinolaryngol· 2026· PMID 41955783recente
  7. Correction: Ortolano et al. Enzymatic Evolution and Longitudinal Recovery in Biotinidase Deficiency: Genotypic and Clinical Insights from the Follow-Up of a Newborn-Screened Cohort in Emilia-Romagna, Italy. Metabolites 2025, 15, 605.
    Metabolites· 2026· PMID 41893366recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:79241(Orphanet)
  2. OMIM OMIM:253260(OMIM)
  3. MONDO:0009665(MONDO)
  4. GARD:894(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q776026(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Deficiência de biotinidase
Compêndio · Raras BR

Deficiência de biotinidase

ORPHA:79241 · MONDO:0009665
🇧🇷 Brasil SUS
Triagem
Atividade de biotinidase em sangue seco
PNTN
Fase 1 · Nacional
Incidência BR
1:60.000
Geral
Prevalência
1-9 / 100 000
Herança
Autosomal recessive
CID-10
E53.8 · Deficiência de outras vitaminas especificadas do grupo B
CID-11
Ensaios
2 ativos
Início
Adolescent, Adult, Childhood, Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0220754
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades